Guangzhou Guanghua Pharmaceutical

Guangzhou Baiyunshan Guanghua Pharmaceutical is a prominent Chinese pharmaceutical company and a subsidiary of Guangzhou Baiyunshan Pharmaceutical Holdings. With a history dating back to 1912, the company specializes in the research, development, and manufacturing of both Traditional Chinese Medicine (TCM) and modern chemical pharmaceuticals. It is best known for its flagship product, Xiao Chai Hu granules, which is a leading treatment for the common cold and flu in the Chinese market. The company operates large-scale GMP-certified manufacturing facilities and maintains a strong presence in the over-the-counter (OTC) and prescription drug sectors. As part of the larger Guangzhou Pharmaceutical Group, it leverages extensive resources for distribution and innovation within the healthcare industry.